Skip to main content

Want a detailed portfolio tracker?

Hoth Therapeutics (HOTH) P/E (2019 - 2026)

Hoth Therapeutics (HOTH) P/E from Apr 1, 2019 to Jul 21, 2026. The TTM Hoth Therapeutics (HOTH) P/E is -1.09. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Hoth Therapeutics (HOTH)

YearP/EChange
2026-1.09-3.86%
2025-1.13+110.31%
2024-0.54+63.53%
2023-0.33-56.00%
2022-0.75-31.53%
2021-1.09-74.29%
2020-4.25-46.93%
2019-8.00N/A

Comparison Hoth Therapeutics (HOTH) P/E with competitors

Hoth Therapeutics (HOTH) P/E is -1.09.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.16%
NBYStablecoin Development Corp0.00-100.40%
ENLVEnlivex Ltd0.07-106.88%
FGENFibroGen Inc0.24-122.08%
CHRSCoherus Biosciences Inc0.85-178.05%
FBIOFortress Biotech Inc0.95-187.30%
ORMPOramed Pharmaceuticals Inc1.50-238.26%
AGENAgenus Inc3.01-376.83%
INVAInnoviva Inc3.15-390.12%
VXRTVaxart Inc3.55-426.52%
CRMDCorMedix Inc3.63-433.76%
CVACCureVac N.V.4.45-508.93%
GLPGGalapagos NV4.86-546.94%
SRPTSarepta Therapeutics Inc4.88-549.07%
ABEOAbeona Therapeutics Inc5.39-595.56%
ABUSArbutus Biopharma Corp5.60-614.70%
ZVRAZevra Therapeutics Inc5.89-641.53%
SPROSpero Therapeutics Inc6.23-672.91%
CGENCompugen Ltd6.31-680.78%
RIGLRigel Pharmaceuticals6.87-732.12%
SLXNSilexion Therapeutics Corp7.30-771.12%
OMEROmeros Corporation9.26-951.65%
AUPHAurinia Pharmaceuticals Inc9.58-981.66%
PLXProtalix BioTherapeutics Inc10.89-1101.79%
ACADAcadia Pharmaceuticals Inc11.73-1178.83%
TBPHTheravance Biopharma Inc12.26-1227.91%
ADMAAdma Biologics Inc12.42-1242.26%
HRMYHarmony Biosciences Holdings Inc13.82-1371.23%
SABSSAB Biotherapeutics Inc14.14-1400.30%
NAGENiagen Bioscience Inc14.82-1463.02%
INCYIncyte Corp15.82-1555.42%
REGNRegeneron Pharmaceuticals Inc15.86-1558.55%
PBYIPuma Biotechnology Inc17.32-1692.76%
CPRXCatalyst Pharmaceuticals Inc17.44-1704.13%
EXELExelixis Inc17.54-1713.21%
TGTXTG Therapeutics Inc18.97-1844.57%
MDXGMimedx Group Inc20.55-1990.49%
XOMAXOMA Royalty Corp22.87-2204.15%
ARGXArgen X SE24.30-2335.08%
CTMXCytomX Therapeutics Inc24.82-2383.20%
XOMAOXOMA Royalty Corp25.34-2431.37%
HALOHalozyme Therapeutics Inc25.62-2457.02%
XOMAPXOMA Royalty Corp25.67-2461.29%
VRTXVertex Pharmaceuticals Inc27.99-2675.13%
RPRXRoyalty Pharma plc - Class A28.69-2738.85%
SLNOSoleno Therapeutics Inc29.02-2769.01%
ASNDAscendis Pharma A/S30.09-2867.45%
LGNDLigand Pharmaceuticals Inc - Class B37.91-3587.38%
APLSApellis Pharmaceuticals Inc39.02-3689.41%
BMRNBiomarin Pharmaceutical Inc42.21-3982.90%
KRYSKrystal Biotech Inc45.34-4270.97%
ONCBeiGene Ltd69.54-6496.75%
PHARPharming Group N.V.75.03-7001.31%
TECHBio-Techne Corp101.96-9478.76%
VCELVericel Corp109.92-10211.24%
ALNYAlnylam Pharmaceuticals Inc117.96-10951.15%
GMABGenmab140.29-13004.80%
TLXTelix Pharmaceuticals Ltd162.15-15015.81%
CORTCorcept Therapeutics Inc212.86-19679.94%